Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (211-220 of 369) with videos related to

Pageof 37
Sort By:
Plos One|June 26, 2019
Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosisHiba Younis, Isabell Kerschbaumer, Jee-Young Moon, et al.
BMC Infectious Diseases|August 30, 2007
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South AfricaStephen D Lawn, Nonzwakazi Bangani, Monica Vogt, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2006
Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis controlRobin Wood, Keren Middelkoop, Landon Myer, et al.
The Journal of Infectious Diseases|January 18, 2022
Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical DataKathrin Zürcher, Julien Riou, Carl Morrow, et al.
The Journal of Infectious Diseases|September 22, 2009
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalenceKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Plos One|December 15, 2010
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan AfricaMartin W G Brinkhof, Ben D Spycher, Constantin Yiannoutsos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patientsRobin Wood, Joseph Eron, Keikawus Arasteh, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2012
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureMary-Ann Davies, Andrew Boulle, Karl Technau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
Pageof 37

Showing results (211-220 of 369) with videos related to

Sort By:
Pageof 37
Plos One|June 26, 2019
Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosisHiba Younis, Isabell Kerschbaumer, Jee-Young Moon, et al.
BMC Infectious Diseases|August 30, 2007
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South AfricaStephen D Lawn, Nonzwakazi Bangani, Monica Vogt, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2006
Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis controlRobin Wood, Keren Middelkoop, Landon Myer, et al.
The Journal of Infectious Diseases|January 18, 2022
Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical DataKathrin Zürcher, Julien Riou, Carl Morrow, et al.
The Journal of Infectious Diseases|September 22, 2009
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalenceKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Plos One|December 15, 2010
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan AfricaMartin W G Brinkhof, Ben D Spycher, Constantin Yiannoutsos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patientsRobin Wood, Joseph Eron, Keikawus Arasteh, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2012
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureMary-Ann Davies, Andrew Boulle, Karl Technau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
Pageof 37